Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Unicycive Therapeutics Inc UNCY

Healthcare Biotechnology
Unicycive Therapeutics, Inc. is a biotechnology company that is developing treatments for certain medical conditions. Its programs are focused on kidney disease, an area that has the potential to offer medical benefits. Its development programs are focused on two novel therapies: Oxylanthanum Carbonate, and UNI 494. Oxylanthanum Carbonate is a novel investigational phosphate binding agent being... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:UNCY)

Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National Kidney Foundation Spring Clinical Meeting

GlobeNewswire 3 days ago

Unicycive Announces First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 4 days ago

Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference

GlobeNewswire April 10, 2024

Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire March 28, 2024

Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association Congress

GlobeNewswire March 25, 2024

Unicycive Announces $50 Million Private Placement

GlobeNewswire March 14, 2024

Unicycive Therapeutics Delivers Both an Oral and Poster Presentation on UNI-494 at the AKI and CRRT Conference

GlobeNewswire March 13, 2024

Unicycive Therapeutics Completes Enrollment in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC)

GlobeNewswire March 7, 2024

Unicycive Therapeutics Announces Orphan Drug Designation Granted for UNI-494 by the U.S. Food and Drug Administration for the Prevention of Delayed Graft Function in Kidney Transplant Patients

GlobeNewswire March 4, 2024
View More News ››

Opinion & Analysis (NDAQ:UNCY)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:UNCY)

UNCY....flirting with VWAP

Cheers !
Iseneschal - March 10, 2023

UNCY .... thru RBL at $2.63.... on watch still

it better get going.....Me no position
Iseneschal - March 10, 2023

UNCY.....now right in the "thick of res"....$2.50

N>H>O>D.......... All looks good...could go way higher.... I don't know ; ) I just want to say that.... Stops save...
Iseneschal - March 10, 2023

RE:UNCY .....The trend continues....Day 6 of run....Sheesh

I failed to mention that my chart tells me there congestion at this level.....resistance start at ~ $2.32 Cheers
Iseneschal - March 10, 2023

UNCY .....The trend continues....Day 6 of run....Sheesh

Close Prices Last 3 Months Price/volumes not adjusted for restructures Date Ex ...
Iseneschal - March 10, 2023

UNCY....ripping in the pre-market open

Volume & price action no position  Cheers !
Iseneschal - March 9, 2023
View more Bullboard ››

Noble Mineral Exploration Inc.

Noble Mineral Exploration Inc.

Noble Mineral Exploration Inc. is a Canada-based junior exploration company. The Company is engaged in the exploration and ...
View More »